✦ LIBER ✦

Tumour bed irradiation of human tumour xenografts in a nude rat model using a common X-ray tube

✍ Scribed by S. V. Tokalov; W. Enghardt; N. Abolmaali

Book ID: 107583243
Publisher: Indian Academy of Sciences
Year: 2010
Tongue: English
Weight: 295 KB
Volume: 35
Category: Article
ISSN: 0250-5991
DOI: 10.1007/s12038-010-0024-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of circulating antigen on the

Influence of circulating antigen on the biodistribution and tumour localization of radiolabelled monoclonal antibody in a human tumour: Nude mouse xenograft model

✍ Pimm, M.V.; Durrant, L.G.; Baldwin, R.W. 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 766 KB

In vivo tumour extracellular pH monitori

In vivo tumour extracellular pH monitoring using electron paramagnetic resonance: the effect of X-ray irradiation

✍ Goodwin, Jonathan; Yachi, Katsuya; Nagane, Masaki; Yasui, Hironobu; Miyake, Yusu 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

INITIAL EXPERIENCE WITH EVALUATION OF BL

INITIAL EXPERIENCE WITH EVALUATION OF BLADDER TUMOUR GROWTH IN THE NUDE RAT USING A NEWLY DEVELOPED MINI ENDOSCOPE: A NEW ORTHOTOPIC TRANSITIONAL CELL CANCER MODEL

✍ C. Bolenz; Y. Cao; M. Wenzel; M. Fernandez; L. Trojan; P. Alken; M.S. Michel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Investigation of 5-FU disposition after

Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

✍ Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5‐FU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5‐FU and 5‐F